£30 million investment in three new Innovation Centres in Scotland leads the way for international business and academia to collaborate on medical research.
In April 2013, The Scottish Government announced the creation of three new Innovation Centres in Scotland. The centres, focusing on stratified medicine, digital health and imaging research are supported by a core investment of £28 million from the Scottish Funding Council over five years.
The University of Glasgow is set to boost its contribution to global medical research and the Scottish economy following the announcement of funding to build a major research centre.
The Scottish Funding Council is providing £8 million over five years to back the creation of the £20 million Stratified Medicine Scotland Innovation Centre (SMS-IC) at the new South Glasgow Hospitals Campus.
The SMS-IC will also involve a consortium of other universities, NHS Scotland, and industry partners. Construction work is expected to begin in November this year, with a fully-operational centre due to open in September 2015.
The other two centres at the University of Glasgow and the University of Edinburgh will develop state-of-the-art sensors and imaging systems and digital health technologies ensuring that Scotland continues to be a pioneer in life sciences, innovative technology, ideas and development.
Professor Anna Dominiczak, Vice-Principal and Regius Professor of Medicine at the University of Glasgow, said:
“The Stratified Medicine Scotland Innovation Centre is a once in a lifetime opportunity to combine our strengths in life science industry, NHS health delivery and academic medicine to produce world-leading innovations for treatment of chronic diseases.
Ideal location for clinical trials
“The South Glasgow Hospitals Campus is the ideal location for the Innovation Centre, as it is one of the largest hospital facilities in Europe and located in an area with a high prevalence of chronic diseases. It will also be linked physically to the planned Clinical Research Facility for stratified clinical trials.
“Researchers will benefit from access to sequenced human genomes combined with clinical data, enabling world-leading developments in stratified medicine in chronic diseases.”
The Universities of Aberdeen, Edinburgh and Dundee will also be involved in the research conducted at the SMS-IC, along with NHS Greater Glasgow and Clyde, NHS Grampian, NHS Lothian and NHS Tayside.
The SMS-IC consortium has already secured a commitment of £2 million in cash and £4.6 million in kind investment for the project from core business partners, including SMEs. The key business partners are Life Technologies and Aridhia.
Peter Silvester, President Europe, Middle East & Africa of Life Technologies, said: “The Stratified Medicine Scotland Innovation Centre is a ground breaking project that represents a real opportunity to change the way healthcare will be practised.
“Life Technologies will provide facilities and the genetic analysis platform with its semiconductor based, Ion ProtonTM DNA sequencing technology, at a speed, accuracy and cost that would have been impossible just a few months ago."
Welcoming the announcement, Dr Lena Wilson, Chief Executive, Scottish Enterprise said:
“These new innovation centres will provide ideal breeding grounds for business and academia to collaborate.
“We expect the businesses that engage with the centres to create high quality demand for our range of innovation and R&D support.
“In this way, and by working with our partners, we can further help Scotland's ambitious innovation-based businesses to develop advanced products for the global marketplace."
In their first five years, the three centres are projected to create more than 2000 jobs.
Contact us to learn more about Scotland's partnering opportunities